Second Genome Presents Data at the World Microbe Forum Demonstrating Application of its Computational Platform sg-4-sight to Identify Peptides that Have the Potential to Modulate T Cell Activity in Inflammatory Bowel Disease (IBD)
June 22, 2021, BRISBANE, Calif
Second Genome to Present Big Data Analytics Capabilities at the Microbiome Data Congress
June 9, 2021, Brisbane, Calif
Second Genome to Present at the Jefferies Microbiome-Based Therapeutics Summit
April 15, 2021, Brisbane, Calif
Second Genome Appoints Dr. Susannah Cantrell to Chief Business Officer and Dr. Preeti Gupta Lal to Chief Scientific Officer
January 25, 2021, Brisbane, CA
Second Genome To Present Biomarker Data in Oncology at Keystone Symposium
January 19, 2021, South San Francisco, CA
Second Genome To Present at Biotech Showcase Digital 2021 Conference
January 11, 2021, South San Francisco, CA
Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery
April 6, 2020, Foster City, CA & South San Francisco, CA
FORTUNE and Great Place to Work Name Second Genome a "Top 10 Best Workplace in Biopharma"
April 10, 2019, South San Francisco, CA
